Quantcast

Latest European Association of Urology Stories

2013-03-18 11:12:57

Men who participate in biennial PSA based screening have a lower risk of being diagnosed as well as dying from prostate cancer up to 9 years after their last PSA test, according to the results of a new study to be presented at the 28th Annual EAU Congress in Milan A joint Swedish-UK study aimed to examined the risk of developing prostate cancer after last invitation to screening. This investigation follows up on previous publication from the Göteborg randomized screening trial...

2013-03-18 11:08:57

A genetic score based on PCa risk-associated single nucleotide polymorphisms (SNPs) is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China. The authors, who relate their findings to the male population in China, also suggest that this score can improve predictive performance of existing clinical variables, especially for patients with a total PSA...

2013-02-11 15:48:20

The safety of the patient is the prime consideration During the final day of the 28th Annual EAU Congress, which will take place on 15-19 March 2013 in Milan, the European Association of Urology will release its official policy statement on live surgery ethics. The statement and accompanying commentary will be delivered by Mr. Keith Parsons (Liverpool, UK), who chairs the EAU Guidelines Office and is a member of the working panel which was tasked with formulating the policy. Chaired by...

2011-07-21 12:19:00

RESTON, Va., July 21, 2011 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), a leader in the development of innovative, online, print, and live interactive continuing medical education and portal technologies for healthcare professionals, is pleased to announce the launch of its newest healthcare professional specialty portal, CCO Urology. CCO Urology content will include topics of interest to urologists, including prostate cancer, renal cell carcinoma, bladder cancer, and advances in...

2011-03-22 09:36:00

TOKYO, March 22, 2011 /PRNewswire-FirstCall/ -- Astellas Pharma Inc.(TSE:4503,"Astellas") ( http://www.astellas.com/en/corporate/) today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition[1,2]. These data were presented for the first time this week at...

2010-09-15 16:51:06

Latest TNS NIPO study underlines need for wide-scale, reliable screening A recent TNS NIPO survey, on behalf of the Dutch Association of Urology (NVU) and the European Association of Urology (EAU), showed that almost four out of 10 Dutch men of 50 years and older suffer, or have suffered, from urinary complaints. The same number of men also said in the same survey they are worried that they may have prostate cancer. The TNS NIPO survey also indicated that a significantly larger number of men...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related